In the series of POLE-mutated undifferentiated and dedifferentiated endometrial carcinomas reported by Espinosa et al. [90], the neoplasms were more frequently stage I and the patients had a better prognosis than for other carcinomas lacking this mutational status. The gene discussed is POLE; the disease is endometrial carcinoma.